Stockscreener 앱 받기
0.77%
시간 외 거래:
전일 마감가:
$324.86
열려 있는:
$324.13
하루 거래량:
3.84M
Relative Volume:
1.23
시가총액:
$175.61B
수익:
$33.42B
순이익/손실:
$4.09B
주가수익비율:
43.36
EPS:
7.55
순현금흐름:
$10.39B
1주 성능:
+5.33%
1개월 성능:
+11.05%
6개월 성능:
-0.48%
1년 성능:
+19.58%
1일 변동 폭
$322.77
$335.88
1주일 범위
$310.14
$335.88
52주 변동 폭
$253.30
$346.85
암젠 Stock (AMGN) Company Profile
명칭
Amgen Inc
전화
(805)447-1000
주소
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
AMGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
327.36 | 175.61B | 33.42B | 4.09B | 10.39B | 7.55 |
|
LLY
Lilly Eli Co
|
829.76 | 788.61B | 45.04B | 10.59B | 414.30M | 11.71 |
|
ABBV
Abbvie Inc
|
216.66 | 382.48B | 56.33B | 4.28B | 17.83B | 2.40 |
|
NVO
Novo Nordisk Adr
|
78.95 | 350.46B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
JNJ
Johnson Johnson
|
167.70 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
MRK
Merck Co Inc
|
95.23 | 251.88B | 64.17B | 17.12B | 18.10B | 6.73 |
암젠 Stock (AMGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Outperform |
| 2024-10-14 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-05-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 재개 | Raymond James | Mkt Perform |
| 2024-02-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-02 | 업그레이드 | Truist | Hold → Buy |
| 2023-10-20 | 재개 | JP Morgan | Neutral |
| 2023-10-17 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 재개 | BofA Securities | Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-04-24 | 재확인 | Oppenheimer | Outperform |
| 2023-03-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 재확인 | Truist | Buy |
| 2022-11-18 | 개시 | Credit Suisse | Underperform |
| 2022-10-31 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-02-09 | 재확인 | Barclays | Equal Weight |
| 2022-02-09 | 재확인 | Jefferies | Buy |
| 2022-02-09 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 재확인 | Oppenheimer | Outperform |
| 2022-02-09 | 재확인 | Wells Fargo | Equal Weight |
| 2022-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-09-23 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 개시 | Daiwa Securities | Buy |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-10-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | 업그레이드 | Truist | Hold → Buy |
| 2020-10-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | 다운그레이드 | Truist | Buy → Hold |
| 2020-10-08 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 재개 | Guggenheim | Neutral |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-03-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-17 | 재개 | Morgan Stanley | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-11-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-19 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-05-23 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
암젠 주식(AMGN)의 최신 뉴스
Candriam S.C.A. Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen, Fresenius Settle Osteoporosis Drug Patent Dispute - Law360
Amgen: Riding The MariTide Of Monthly Weight Loss (NASDAQ:AMGN) - Seeking Alpha
Amgen : Update on Patent Litigation Related to Fresenius Denosumab Biosimilar Products - Marketscreener.com
Amgen continues gains for seven straight sessions (AMGN:NASDAQ) - Seeking Alpha
Callan Family Office LLC Acquires 11,801 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen, Fresenius Settle Suit Over Prolia, Xgeva Biosimilars (1) - Bloomberg Law
Amgen And Kyowa Kirin's Rocatinlimab Reduces Eczema Severity In Phase 3 Study - Benzinga
Protein Engineering Market Projected To Witness Substantial Growth, 2025-2032: Agilent Technologies Inc., - EIN News
AMGN's Eczema Drug Meets Goal in Two Late-Stage Studies - Zacks Investment Research
Amgen’s rocatinlimab picks up steam with late-stage atopic dermatitis win - PharmaLive
Argentarii LLC Makes New $357,000 Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Sound View Wealth Advisors Group LLC Purchases 1,159 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Ellerson Group Inc. ADV Has $3.17 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Samsung, Celltrion lead biosimilar market in Europe, US - Korea Economic Daily
Amgen, Kyowa Kirin’s rocatinlimab trial for atopic dermatitis meets endpoints - Yahoo Finance
Daiwa Securities Group Inc. Has $54.26 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
2,128 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by Vista Investment Partners II LLC - MarketBeat
Amgen and Kyowa Kirin announce rocatinlimab Phase III success - The Pharma Letter
Meriwether Wealth & Planning LLC Makes New $417,000 Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Take the Zacks Approach to Beat the Markets: NioCorp, AngloGold, Amgen in Focus - Zacks Investment Research
Zurcher Kantonalbank Zurich Cantonalbank Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Sowell Financial Services LLC Decreases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
OFI Invest Asset Management Buys New Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Sells 5,274 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Banco Santander S.A. - MarketBeat
Cancer Biologics Market Projected To Witness Substantial Growth 2025-2032:Amgen Inc., Pfizer Inc., Sanofi S.A, - EIN News
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Verdence Capital Advisors LLC - MarketBeat
E Fund Management Co. Ltd. Increases Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
What is William Blair’s Forecast for Amgen Q4 Earnings? - Defense World
Amgen (NASDAQ:AMGN) Given New $294.00 Price Target at Bank of America - MarketBeat
Townsend Asset Management Corp NC ADV Purchases 2,166 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
What is William Blair's Forecast for Amgen Q4 Earnings? - MarketBeat
Beacon Harbor Wealth Advisors Inc. Buys Shares of 13,548 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Ethos Financial Group LLC Acquires 923 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Raymond James Financial Inc. Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Cullen Frost Bankers Inc. Has $23.93 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Atria Investments Inc Sells 2,435 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Arizona State Retirement System Has $40.55 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen, Inc. to Host Earnings Call - ACCESS Newswire
HM Payson & Co. Increases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Rialto Wealth Management LLC Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Kendall Capital Management Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amundi Has $687.47 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Intellectus Partners LLC Buys New Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Machina Capital S.A.S. Lowers Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Andra AP fonden Purchases 12,400 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
1 Dividend Stock Down 30% to Buy and Hold for the Next Decade - The Motley Fool
Generali Investments CEE investicni spolecnost a.s. Purchases Shares of 14,720 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
PNC Financial Services Group Inc. Sells 21,757 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Q1 Earnings Forecast for Amgen Issued By William Blair - Defense World
암젠 (AMGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.34%
0.17%
자본화:
|
볼륨(24시간):